Literature DB >> 8782837

High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy.

T Hirano1, H Naito, M Kurokawa, T Ebara, S Nagano, M Adachi, G Yoshino.   

Abstract

To determine whether small-sized low density lipoprotein (LDL) is associated with a high incidence of coronary heart disease in diabetic nephropathy, we measured the LDL particle size in non-insulin-dependent diabetes mellitus (NIDDM) patients with various degrees of albuminuria (n = 95) and age-, weight-matched non-diabetic control subjects (n = 31). The diabetic subjects were divided into three groups, normoalbuminuric, microalbuminuric and macroalbuminuric NIDDM, based on the amount of albuminuria. The average diameter of LDL particles was determined by non-denaturing polyacrylamide gradient (2-16%) gel electrophoresis. The plasma lipid and lipoprotein concentrations were comparable between the non-diabetic controls and normoalbuminuric NIDDM, whereas the plasma triglyceride, very-low-density lipoprotein (VLDL) or LDL concentration was significantly increased in diabetic nephropathy. The mean LDL particle size was significantly smaller in microalbuminuric NIDDM compared with the controls or normoalbuminuric NIDDM, and the LDL size was further decreased in macroalbuminuric NIDDM. The incidence of small LDL (diameter < 255 A) was remarkably increased in microalbuminuric (58%) and macroalbuminuric NIDDM (67%) compared to the control (13%) and normoalbuminuric NIDDM (27%). Corresponding to the decreased LDL size, the cholesterol content of the LDL was significantly depleted in NIDDM with nephropathy. The high prevalence of small LDL in diabetic nephropathy was also observed even when hypertriglyceridemic or hypertensive subjects were excluded from each group. The increment in triglyceride-rich lipoprotein (d < 1.006) after oral fat-loading was increased, and postheparin lipoprotein lipase activity was decreased significantly in diabetic nephropathy. These abnormalities were significantly associated with LDL particle size. Multivariate regression analysis revealed that the amount of albuminuria was closely associated with the average LDL particle size, and this association was independent of the plasma triglyceride level. Neither insulin resistance nor glycemic control was directly associated with LDL particle diameter. The present study indicates that LDL particles become smaller in diabetic nephropathy, and this may be associated primarily with abnormal triglyceride metabolism. However, in addition to hypertriglyceridemia, other metabolic abnormalities caused by diabetic nephropathy may also be involved in the pathogenesis of small LDL particles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8782837     DOI: 10.1016/0021-9150(95)05772-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

Review 1.  Dyslipidemia in diabetes mellitus and cardiovascular disease.

Authors:  Haider J Warraich; Jamal S Rana
Journal:  Cardiovasc Endocrinol       Date:  2017-02-15

Review 2.  Role for combination therapy in diabetic dyslipidemia.

Authors:  Haider J Warraich; Nathan D Wong; Jamal S Rana
Journal:  Curr Cardiol Rep       Date:  2015-05       Impact factor: 2.931

3.  Protective effect of oleuropein, an olive oil biophenol, on low density lipoprotein oxidizability in rabbits.

Authors:  E Coni; R Di Benedetto; M Di Pasquale; R Masella; D Modesti; R Mattei; E A Carlini
Journal:  Lipids       Date:  2000-01       Impact factor: 1.880

4.  Lower levels of total HDL and HDL3 cholesterol are associated with albuminuria in normoalbuminuric Type 1 diabetic patients.

Authors:  T Bulum; B Kolaric; L Duvnjak
Journal:  J Endocrinol Invest       Date:  2013-02-12       Impact factor: 4.256

5.  Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Ian H de Boer; Brad C Astor; Holly Kramer; Walter Palmas; Kyle Rudser; Stephen L Seliger; Michael G Shlipak; David S Siscovick; Michael Y Tsai; Bryan Kestenbaum
Journal:  Atherosclerosis       Date:  2007-08-06       Impact factor: 5.162

6.  Effects of fenofibrate on albuminuria in patients with hypertriglyceridemia and/or hyperuricemia: a multicenter, randomized, double-blind, placebo-controlled, crossover study.

Authors:  Tsutomu Kazumi; Tsutomu Hirano; Gen Yoshino
Journal:  Curr Ther Res Clin Exp       Date:  2003-07

Review 7.  Abnormal lipoprotein metabolism in diabetic nephropathy.

Authors:  Tsutomu Hirano
Journal:  Clin Exp Nephrol       Date:  2013-10-17       Impact factor: 2.801

8.  Lipid Abnormalities in Type 2 Diabetes Mellitus Patients with Overt Nephropathy.

Authors:  Sabitha Palazhy; Vijay Viswanathan
Journal:  Diabetes Metab J       Date:  2017-04       Impact factor: 5.376

9.  Small dense low-density lipoprotein as a potential risk factor of nephropathy in type 2 diabetes mellitus.

Authors:  Essam Abd-Allha; Basma Badr Hassan; Mohamad Abduo; Seham Ahmed Omar; Hamdy Sliem
Journal:  Indian J Endocrinol Metab       Date:  2014-01

Review 10.  Urolithins: Diet-Derived Bioavailable Metabolites to Tackle Diabetes.

Authors:  Ana F Raimundo; Sofia Ferreira; Francisco A Tomás-Barberán; Claudia N Santos; Regina Menezes
Journal:  Nutrients       Date:  2021-11-27       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.